(GELS - GELTEQ LTD)

company profile

Gelteq Limited focuses on developing and commercializing white label gel-based delivery solutions for humans and animals in the United States of America, China and Australia. It offers edible gels for prescription drugs, nutraceuticals, pet care, and other products, as well as for sports and over-the-counter products. Gelteq Limited was incorporated in 2017 and is headquartered in Clayton, Australia.

Gelteq (GELS) is trading at 0.7001

Open Price
0.7801
Previous close
0.7001
Previous close
0.7001
P/E Ratio
0
Sector
Health Care
Shares outstanding
10711059
Primary exchange
NASDAQ-NMS
ISIN
AU0000218109